Shenzhen Chipscreen Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shenzhen Chipscreen Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shenzhen Chipscreen Bioscience Today - Breaking & Trending Today

Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan

Published: December 1, 2021

/PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide...

Source: prnewswire.com

Related Topics:

Kensei TobinaiChidamide TucidinostatChipscreen BioscienceChipscreen BiosciencesLu XianpingMireille GillingsHuya InternationalMinistry Of HealthUnited StateShenzhen Chipscreen Biosciences Co LtdScientist Of The National Cancer Center HospitalShenzhen Chipscreen BioscienceVisiting ScientistNational Cancer Center HospitalChidamide PhaseObjective Response RateProgression Free SurvivalOverall SurvivalShenzhen Chipscreen BiosciencesEpigenetic ImmunomodulatorMeiji SeikaStock SymbolShenzhen Chipscreen Biosciences Co

Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan

Published: December 1, 2021

/PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide...

Source: prnewswire.com

Related Topics:

Kensei TobinaiChidamide TucidinostatChipscreen BioscienceChipscreen BiosciencesLu XianpingMireille GillingsHuya InternationalMinistry Of HealthUnited StateShenzhen Chipscreen Biosciences Co LtdScientist Of The National Cancer Center HospitalShenzhen Chipscreen BioscienceVisiting ScientistNational Cancer Center HospitalChidamide PhaseObjective Response RateProgression Free SurvivalOverall SurvivalShenzhen Chipscreen BiosciencesEpigenetic ImmunomodulatorMeiji SeikaStock SymbolShenzhen Chipscreen Biosciences Co